OncoRef BRCA1/2®

Susceptibility to hereditary breast cancer

/
/
/
RefLab OncoRef BRCA

The importance in diagnosing hereditary breast cancer

Breast cancer is the most common cancer in women, representing 29% of all oncological illnesses.

Approximately 5-10% of cases of breast cancer are hereditary.

Test code: 12712

Sample requirements:

    • 5mL whole blood EDTA
    • 1 RefLabCard®
    • Purified DNA (≥ 30ng/uL in ≥ 100uL)

Informed consent must be sent with the sample

BRCA1/2 genes contain more than 25% of the genetic variants responsible for the development of hereditary breast cancer.

Genetic study of hereditary cancer is essential to ensure the correct treatment, diagnosis and care of the patient. What’s more it’s vitally important for other family members, who could also show a positive test result.

Susceptibility to breast cancer and BRCA1/2 genes

Patients who show the pathogenic gene variant in BRCA1/2 genes are at greater risk of developing breast cancer throughout their lives. More specifically, 60% in cases of BRCA1 and 50% in cases of BRCA2.

Advantages of OncoRef BRCA1/2®

Before the identification of the pathogenic gene variant in BRCA1/2 genes, we can implement preventative measures in patients diagnosed with breast or ovarian cancer, as well as family members who show the gene variant.

When to carry out a genetic study for hereditary breast cancer

High risk pathological-clinical criteria of hereditary breast cancer and ovarian cancer:

How to order?

Check our sample requirements

Genetic Counseling Support

Ordering a test or Service from
us is simple and quick

We accept a wide range
of samples

Get pre and postanalysis
genetic counseling

How to order?

Ordering a test or Service from
us is simple and quick

Check our sample requirements

We accept a wide range
of samples

Genetic Counseling Support

Get pre and postanalysis
genetic counseling

Get our latest updates
directly to your mailbox

error: Content is protected
×